PMID: 11910679Mar 26, 2002Paper

Regulation of endometrial angiogenesis

Climacteric : the Journal of the International Menopause Society
M C ReesR Bicknell

Abstract

Bleeding problems are the most common reason for discontinuation of hormone replacement therapy. Human endometrium undergoes the unique process of benign angiogenesis under the control of ovarian steroids during reproductive life and it is presumed that similar processes occur when women take hormone replacement therapy. The key players in endometrial growth and angiogenesis are vascular endothelial growth factor, thymidine phosphorylase and adrenomedullin. Regulation of these angiogenic factors is described.

References

Dec 1, 1990·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·S TabibzadehP G Satyaswaroop
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D MaglioneM G Persico
May 1, 1991·Human Reproduction·K SmithM C Rees
Aug 1, 1989·The Anatomical Record·I R Kaiserman-Abramof, H A Padykula
Feb 1, 1994·International Journal of Cancer. Journal International Du Cancer·T YamamotoV Petrow
Mar 17, 1994·Nature·M HaraguchiY Yamada
Mar 1, 1994·Human Reproduction·A M Goodger, P A Rogers
Jul 30, 1993·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Aug 30, 1994·Biochemical and Biophysical Research Communications·T IshimitsuH Matsuo
Apr 30, 1993·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Aug 1, 1995·Human Reproduction·J GrimwoodM C Rees
Jan 15, 1996·The Journal of Clinical Investigation·M L Iruela-ArispeE H Sage
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·B OlofssonU Eriksson
Sep 20, 1996·The Journal of Biological Chemistry·M J MillerF Cuttitta
Sep 1, 1996·Human Reproduction·M HickeyP A Rogers
Oct 1, 1996·Human Reproduction·S B SubakirB Affandi
Oct 23, 1997·British Journal of Obstetrics and Gynaecology·D W Sturdee
Oct 1, 2003·Angiogenesis·M C Rees, R Bicknell

❮ Previous
Next ❯

Citations

May 18, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Azad Ahmad AhangerDinesh Kumar
Jun 18, 2003·Biochemical and Biophysical Research Communications·Ali YilmazJohannes Waltenberger
Apr 2, 2003·Regulatory Peptides·E ZudaireF Cuttitta
Apr 13, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·V W van Hinsbergh
Apr 12, 2000·Maturitas·M Dören
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·F E Riphagen
Jun 23, 2009·Drug and Chemical Toxicology·Sohail EjazChae Woong Lim
Oct 7, 2004·Pharmacology & Therapeutics·David C BuntonJohn J V McMurray
Feb 23, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Emanuela MarinoniRomolo Di Iorio
Oct 20, 2020·Journal of Hepato-biliary-pancreatic Sciences·Toshifumi KinAkio Katanuma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.